Highlights
• Environmental surveillance is an alternative to case-based surveillance.
• Vaccine targeted to high-risk populations is less expensive than national campaigns.
• Surveillance-based vaccine introductions are more cost-effective than blanket decisions.
• Environmental surveillance is valuable, even if costs are higher than anticipated.